Studies are still under way to determine whether additional booster shots are needed to maintain immunity, but Pfizer’s CEO calls it “a likely scenario.”
Studies are still under way to determine whether additional booster shots are needed to maintain immunity, but Pfizer’s CEO calls it “a likely scenario.”